Flow-mediated endothelial remodeling and inflammation drive developmental vascular susceptibility in ldlr loss of function
23h ago· 1 min readNews
Source
Studying ldlr-/- zebrafish reveals how early endothelial remodeling and inflammation from ldlr loss spur atherosclerosis, the #1 cardiovascular disease cause. PMID:42168212, Nat Commun 2026, @NatureComms #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪
You might also wanna read

The senescence-stiffening loop: How extracellular matrix remodeling, vascular decline, and mitochondrial dysfunction collectively drive tissue aging
This article presents a unified perspective on tissue aging through a "senescence-stiffening loop" — a self-reinforcing cycle involving extr
cell.com·23h ago

Study reveals molecular mechanism linking statins to muscle side effects via NLRP3 inflammasome and protein-prenylation pathway
This scientific research article investigates the molecular mechanisms behind statin-associated myopathy (muscle side effects). The study fi
Fluoxetine disrupts cholesterol metabolism in endothelial cells via SREBP2 activation
nature.com
Cardiovascular Disease Prevention Through Pharmaceutical LDL Reduction
The article argues that cardiovascular disease (CVD) is effectively a solved problem due to modern pharmaceutical interventions. It explains
totalhealthoptimization.com·5mo agoGut Bacteria Molecule Linked to Atherosclerosis, Major Cause of Heart Disease
Spanish scientists discovered that gut bacteria produce a molecule leading to atherosclerosis, a major cause of heart attacks and strokes. T

New plasma proteomics model improves thrombosis risk prediction in cancer patients and identifies IL-17-driven endothelial activation as therapeutic target
This article presents research by Karagkouni and colleagues who developed a new cancer-associated venous thromboembolism (VTE) prediction mo

Comments
Sign in to join the conversation.
No comments yet. Be the first.